BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36468951)

  • 1. Treatment of Reactive Keratoacanthomas with Acitretin Following Multiple Excisions and Mohs Surgery for Recurrent Squamous Cell Carcinoma.
    Weingarten M; Weingarten M; Farah J; Farah R
    J Drugs Dermatol; 2022 Dec; 21(12):1353-1354. PubMed ID: 36468951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of keratoacanthomas and cutaneous squamous cell carcinoma treated with Mohs micrographic surgery.
    Gao DX; Ozog D; Maghfour J; Mi QS; Veenstra J
    J Am Acad Dermatol; 2024 Apr; 90(4):872-874. PubMed ID: 38199281
    [No Abstract]   [Full Text] [Related]  

  • 3. Keratoacanthoma as a postoperative complication of skin cancer excision.
    Goldberg LH; Silapunt S; Beyrau KK; Peterson SR; Friedman PM; Alam M
    J Am Acad Dermatol; 2004 May; 50(5):753-8. PubMed ID: 15097960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmelanoma skin cancer of the head and neck: surgical treatment.
    Akcam TM; Gubisch W; Unlu H
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):455-71. PubMed ID: 23084298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of margins in diagnostic biopsies of nonmelanoma skin cancers.
    Jackson JE; Kelly B; Petitt M; Uchida T; Wagner RF
    J Am Acad Dermatol; 2012 Jul; 67(1):122-7. PubMed ID: 22088427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mohs micrographic surgery: a synopsis.
    Stone JL
    Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
    Foxton G; Delaney T
    Australas J Dermatol; 2011 Feb; 52(1):66-9. PubMed ID: 21332698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple squamous cell carcinomas and eruptive keratoacanthomas in an arc welder.
    Wolfe CM; Green WH; Cognetta AB; Hatfield HK
    Dermatol Surg; 2013 Feb; 39(2):328-30. PubMed ID: 22989050
    [No Abstract]   [Full Text] [Related]  

  • 9. Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma.
    Hamilton JR; Parvataneni R; Stuart SE; Chren MM
    JAMA Dermatol; 2013 May; 149(5):616-8. PubMed ID: 23677098
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant cytology in washings of Mohs micrographic surgery instruments.
    Moran B; Wynne B; Thomas S; Griffin M; McMenamin M; Ormond P
    Dermatol Surg; 2013 Jan; 39(1 Pt 1):133-5. PubMed ID: 22816504
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
    Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
    J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent keratoacanthoma with vascular invasion: a diagnostic and management dilemma.
    Kurien A; Henderson C; Lee S
    Australas J Dermatol; 2009 Aug; 50(3):194-7. PubMed ID: 19659982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
    Lane JE; Kent DE
    Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasizing keratoacanthomas? The difficulties in differentiating keratoacanthomas from squamous cell carcinomas.
    Schnur PL; Bozzo P
    Plast Reconstr Surg; 1978 Aug; 62(2):258-62. PubMed ID: 674415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A primer of Mohs micrographic surgery: common indications.
    Nouri K; Rivas MP
    Skinmed; 2004; 3(4):191-6. PubMed ID: 15249779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep initial Mohs stage for scalp cutaneous squamous cell carcinoma to avoid occult tumor.
    Lederhandler M; Stokar E; Meehan SA; Geronemus RG
    J Am Acad Dermatol; 2020 Apr; 82(4):e129-e130. PubMed ID: 31836558
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion.
    Barrett TL; Greenway HT; Massullo V; Carlson C
    Adv Dermatol; 1993; 8():277-304; discussion 305. PubMed ID: 8240916
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical factors influencing periocular surgical defects after Mohs micrographic surgery.
    Carter KD; Nerad JA; Whitaker DC
    Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):83-91. PubMed ID: 10189634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mohs micrographic surgery in rare cutaneous tumors: a retrospective study at a Brazilian tertiary university hospital.
    Buffo TH; Stelini RF; Serrano JYM; Pontes LT; Magalhães RF; de Moraes AM
    An Bras Dermatol; 2023; 98(1):36-46. PubMed ID: 36369200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.